Eczema Supplements: Evidence-Graded Guide [2026]

The supplement with the strongest evidence for eczema is vitamin D3. A 2016 meta-analysis of nine randomized controlled trials found significant SCORAD improvement in atopic dermatitis patients receiving vitamin D supplementation (Kim et al., 2016). The next tier includes strain-specific probiotics, particularly Lactobacillus rhamnosus GG (Grade B: Kalliomaki 2001, Lancet, 50% reduction in atopic dermatitis risk at two years), and fish oil (Grade B: Bjorneboe 1989, significant itch reduction). Evening primrose oil, once the most popular eczema supplement, has not held up in rigorous trials. A 2013 Cochrane review found no consistent benefit. This guide grades every eczema supplement by evidence quality so you can separate proven interventions from marketing.

Why Eczema Responds to Supplements

Atopic dermatitis involves two simultaneous failures. The skin barrier breaks down, often driven by filaggrin (FLG) gene mutations that weaken the outer layer and increase transepidermal water loss. The immune system tilts toward a Th2-dominant response, overproducing IL-4 and IL-13, which further degrade the barrier and invite Staphylococcus aureus colonization. Up to 90% of eczema patients carry S. aureus on lesional skin.

Nutritional deficiencies are common. Vitamin D levels run significantly lower in atopic dermatitis patients compared to healthy controls (Akan et al., 2020). Zinc deficiency correlates with eczema severity. Omega-3 fatty acid intake in Western diets skews the omega-6 to omega-3 ratio toward pro-inflammatory arachidonic acid metabolites.

The gut-skin axis adds another dimension. Eczema patients show gut dysbiosis documented in multiple cohort studies, with reduced microbial diversity preceding disease onset in infants. The gut barrier, when compromised, allows bacterial products into circulation that prime systemic Th2 inflammation. This is why probiotics and gut-healing interventions show relevance for a condition that appears purely dermatological. For a broader view of eczema as an immune-mediated condition, see our guide to autoimmune disease symptoms.

One emerging signal: Silverberg et al. (2024, JAMA Dermatology) identified an association between dietary sodium intake and eczema severity. The mechanism may involve Th2 amplification through sodium-sensitive immune pathways. This is preliminary. Reducing processed food intake is reasonable regardless.

How We Grade Evidence

Three tiers, based on the quality of human data available for each intervention.

Grade A: Multiple randomized controlled trials (RCTs) or meta-analyses in the target population. Consistent, reproducible results.

Grade B: At least one RCT, strong case series, or robust mechanistic evidence paired with clinical observations. Promising but not definitive.

Grade C: Preliminary evidence only. Animal studies, in vitro data, or small pilot trials.

Grades are condition-specific. A supplement earning Grade A for Hashimoto's may earn Grade C for eczema if the eczema-specific trial data is thin. For a cross-condition overview, see our best supplements for autoimmune disease guide.

Grade A: Strong Evidence

Vitamin D3 + K2

Kim et al. (2016, Nutrients) published a meta-analysis of nine RCTs examining vitamin D supplementation in atopic dermatitis. The pooled result: significant improvement in SCORAD scores. Akan et al. (2020) confirmed that AD patients carry significantly lower serum 25(OH)D levels than matched controls.

The mechanisms run deeper than bone health. The vitamin D receptor (VDR) sits on virtually every immune cell and controls the production of cathelicidin (LL-37), an antimicrobial peptide that defends against S. aureus colonization on eczema-affected skin. When vitamin D is low, LL-37 production drops, and S. aureus flourishes. Vitamin D also promotes regulatory T cell differentiation and suppresses the Th2 overactivity that defines atopic dermatitis.

The VITAL trial (Hahn et al., 2022, BMJ) provided the population-level backdrop: 2,000 IU/day vitamin D3 over 5.3 years reduced confirmed autoimmune disease incidence by 22%. In years four and five, the reduction reached 39%.

Patients using topical corticosteroids long-term should note that systemic absorption, while modest, can contribute to vitamin D depletion over time.

Dosing: 2,000 to 4,000 IU/day vitamin D3 paired with 100 to 200 mcg vitamin K2 (MK-7 form). K2 directs calcium into bone rather than soft tissues. Test serum 25(OH)D every 3 months until stable. Target: 50 to 80 ng/mL. Discuss with your dermatologist, especially if you are on systemic immunosuppressants.

Grade B: Good Evidence

Probiotics: Strain Specificity Is Everything

Generic probiotic labels mean nothing for eczema. Strain identity determines efficacy. The evidence clusters around specific organisms with specific trial data.

Lactobacillus rhamnosus GG (LGG). Kalliomaki et al. (2001, The Lancet) randomized 159 pregnant women with a family history of atopy to receive LGG or placebo during the final weeks of pregnancy and the first six months of the infant's life. At two years, the frequency of atopic dermatitis in the probiotic group was half that of placebo (23% versus 46%). This remains the landmark trial for probiotic prevention of eczema.

Multi-strain combinations. Lee et al. (2008) randomized children with moderate-to-severe AD to a multi-strain probiotic or placebo. SCORAD decreased 30.7% in the probiotic group versus 18.8% in placebo. A 2018 meta-analysis of 25 RCTs confirmed that probiotics significantly reduced SCORAD in atopic dermatitis. A 2025 umbrella meta-analysis (Frontiers in Pediatrics) calculated a weighted mean SCORAD difference of -3.75, statistically significant but modest in absolute terms.

L. salivarius LS01. Drago et al. (2012) demonstrated improvement in adult atopic dermatitis with this strain, addressing a gap: most probiotic eczema trials involve children.

The honest assessment. Prevention evidence is stronger than treatment evidence. Starting probiotics during pregnancy and early infancy reduces AD incidence. Starting probiotics in an adult with established eczema produces more modest benefits. Strain matters: LGG has the deepest evidence base, and Culturelle is the widely available product containing this strain.

Dosing: 10 billion CFU/day or higher. Strain-specific products (LGG, multi-strain blends matching trial formulations) over generic blends. Allow 8 to 12 weeks for assessment. Discuss with your dermatologist.

Fish Oil (EPA/DHA)

Bjorneboe et al. (1989, British Journal of Dermatology) randomized atopic dermatitis patients to fish oil or olive oil placebo. The fish oil group showed significant improvement in itch severity. The mechanism is straightforward: EPA competes with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, reducing production of leukotriene B4 and prostaglandin E2, both of which drive eczema-associated inflammation and itch.

The overall trial landscape is mixed. Some RCTs show benefit; others do not. The inconsistency likely reflects baseline omega-3 status. Patients with low baseline EPA/DHA levels respond more robustly than those already consuming adequate fish.

Fish oil also supports the resolution phase of inflammation through specialized pro-resolving mediators (resolvins, protectins, maresins). Eczema is characterized not just by excessive inflammation but by failure to resolve it. This resolution deficit is a legitimate therapeutic target.

Dosing: 2 to 4 g combined EPA + DHA per day with meals. Triglyceride-form fish oil absorbs better than ethyl ester forms. Allow 8 to 12 weeks for assessment. Doses above 3 g/day have mild anticoagulant properties; discuss with your doctor if you take blood thinners. Most effective when baseline omega-3 intake is low.

Zinc

Zinc deficiency associates with eczema severity across multiple observational studies. Zinc is essential for skin barrier integrity, wound healing, and immune regulation. It supports keratinocyte differentiation, the process that builds a functional stratum corneum.

A combination approach showed particular promise. LGG plus zinc plus vitamin D3 reduced atopic dermatitis severity in infants more than any single intervention alone. The synergy makes biological sense: zinc supports the barrier, vitamin D modulates the immune response, and LGG addresses gut-skin axis dysbiosis.

The grade depends on zinc status. For patients with documented deficiency, correction is Grade B with clear mechanistic rationale. For zinc-replete individuals, the evidence for additional supplementation is Grade C.

Dosing: 15 to 30 mg/day zinc picolinate (well absorbed, less GI irritation than zinc sulfate). Test serum zinc before supplementing. High-dose zinc above 40 mg elemental per day for extended periods depletes copper. Monitor copper if supplementing long term. Discuss with your dermatologist.

Grade C: Preliminary Evidence

Evening Primrose Oil (GLA)

Evening primrose oil is the cautionary tale of eczema supplementation. The rationale was compelling: atopic dermatitis patients show impaired delta-6-desaturase activity, the enzyme that converts linoleic acid to gamma-linolenic acid (GLA). Supplementing GLA directly bypasses the enzymatic bottleneck. Early RCTs (Biagi 1988, Berth-Jones 1993) showed positive results and fueled two decades of recommendations.

Then the Cochrane review arrived. Bamford et al. (2013) examined all available RCTs of evening primrose oil and borage oil for eczema. The conclusion: no consistent benefit across trials when properly analyzed. The earlier positive trials had methodological limitations. The larger, better-designed trials were negative.

This is how evidence evolves. A plausible mechanism and early positive signals gave way to null results under rigorous scrutiny. EPO is not harmful. It simply does not deliver the benefit its biochemical rationale promised.

Dosing if trying despite evidence: 500 mg GLA per day, which requires 4 to 6 g of evening primrose oil capsules (EPO contains approximately 9% GLA). Allow 12 weeks. Manage expectations accordingly.

Quercetin

Quercetin stabilizes mast cells and inhibits histamine release. For the itch-dominant subtype of eczema, this mechanism directly addresses the most debilitating symptom. Quercetin also suppresses NF-kB and reduces IL-4 production, the central cytokine in Th2-driven atopic inflammation.

The problem: no randomized controlled trial has tested quercetin in atopic dermatitis. The evidence base consists of animal studies and in vitro mast cell experiments. Strong mechanistic rationale, zero clinical proof.

Quercetin with bromelain improves bioavailability and adds anti-inflammatory enzymatic activity. The combination is widely used in integrative practice for histamine-related conditions. It remains theoretical for eczema specifically.

Dosing: 250 mg quercetin with 200 mg bromelain, twice daily between meals. Best suited for patients with prominent histamine-driven itch. Discuss with your dermatologist.

Vitamin E

Limited evidence exists for vitamin E in atopic dermatitis. Small, underpowered studies suggest modest benefit as an adjunct antioxidant. Vitamin E supports skin membrane integrity and may reduce oxidative damage to the epidermal barrier.

Dosing: 400 IU mixed tocopherols (not alpha-tocopherol alone) daily with meals. Adjunct only. Not a primary intervention.

Supplements to Avoid with Eczema

Immune stimulators. Ashwagandha, echinacea, elderberry, spirulina, and chlorella all activate immune pathways. Eczema is driven by Th2 overactivity. Amplifying immune activation in any direction risks flaring the Th2 response. The nuance matters: these supplements are marketed as "immune support," which sounds beneficial. For eczema patients, immune stimulation is the problem, not the solution. For the full list across autoimmune conditions, see supplements to avoid with autoimmune conditions.

High-dose vitamin A. Retinoids have dermatological applications, but high-dose oral vitamin A supplementation carries toxicity risk and can worsen skin dryness and peeling at the doses sometimes recommended in natural health circles. Dietary vitamin A from whole foods is sufficient.

Unregulated herbal "eczema cures." The FDA has issued multiple warnings about imported herbal eczema creams containing undisclosed corticosteroids, sometimes at potent prescription strength. Patients unknowingly apply what amounts to clobetasol under the label of "natural treatment." If a topical herbal product works suspiciously well and suspiciously fast, question its contents.

Drug-Supplement Interactions

Five medication classes cover the majority of eczema pharmacotherapy. Each carries supplement interactions worth understanding.

Dupilumab (Dupixent). The leading biologic for moderate-to-severe atopic dermatitis blocks IL-4 and IL-13 signaling. Vitamin D, omega-3, zinc, and probiotics are all compatible. No documented adverse interactions. Dupilumab targets one arm of Th2 inflammation; vitamin D and omega-3 modulate complementary pathways. Inform your dermatologist about all supplements when starting biologic therapy.

JAK inhibitors (upadacitinib, abrocitinib). These oral medications suppress multiple cytokine signaling pathways. Standard supplements (vitamin D, omega-3, zinc, probiotics) are compatible at recommended doses. High-dose immune-modulating supplements should be avoided. Because JAK inhibitors affect broad immune signaling, any supplement that significantly alters immune function warrants discussion with your prescriber.

Topical corticosteroids. The most commonly used eczema treatment. No direct supplement interactions. Long-term widespread use can contribute to skin thinning and modest systemic absorption. Vitamin D supplementation supports bone density and immune function that long-term corticosteroid exposure may subtly compromise.

Methotrexate (for severe AD). Folate supplementation required, taken on a different day than the drug dose. High-dose vitamin C above 1,000 mg may increase toxicity. Zinc and vitamin D are safe. Fish oil at high doses (above 3 g/day) has mild anticoagulant properties; flag for your prescriber.

Cyclosporine. Avoid grapefruit, St. John's wort, and high-dose vitamin E, all of which alter cyclosporine metabolism through CYP3A4 interactions. Standard doses of vitamin D, omega-3, and zinc are compatible. Cyclosporine is nephrotoxic; avoid supplements that stress renal function.

Supplement Timing Schedule

Splitting supplements across the day optimizes absorption and reduces the GI burden that large morning boluses create.

Morning (empty stomach, 30 minutes before food): Probiotics (10 billion CFU LGG or multi-strain). Empty stomach maximizes survival through gastric acid.

With breakfast: Vitamin D3 (2,000 to 4,000 IU) + K2 (100 to 200 mcg). Omega-3 half dose (1 to 2 g EPA + DHA). Fat-soluble supplements require dietary fat for absorption.

With lunch: Quercetin 250 mg + bromelain 200 mg (if using). Omega-3 remaining dose (1 to 2 g). Zinc 15 to 30 mg with food to minimize nausea.

Evening: Vitamin E 400 IU mixed tocopherols with dinner (if using). Magnesium glycinate 200 to 400 mg before bed (supports sleep quality, often disrupted by nocturnal itch).

Expected timelines. Vitamin D: 4 to 8 weeks to reach target serum levels. Probiotics: 8 to 12 weeks for SCORAD changes. Fish oil: 8 to 12 weeks. Zinc (if deficient): 4 to 6 weeks. Evening primrose oil (if trying): 12 weeks minimum. Quercetin: 2 to 4 weeks for itch modulation.

If you take methotrexate or cyclosporine, separate mineral supplements from your medication dose by at least 2 hours.

Frequently Asked Questions

What supplements help eczema the most?

Vitamin D3 has the strongest evidence. A meta-analysis of nine RCTs showed significant SCORAD improvement in atopic dermatitis patients (Kim et al., 2016). Strain-specific probiotics (particularly L. rhamnosus GG) carry Grade B evidence, with the landmark Kalliomaki 2001 Lancet trial showing 50% AD risk reduction. Fish oil (EPA/DHA) earned Grade B for itch reduction. The foundation protocol for eczema supplementation is vitamin D3 plus K2, a strain-specific probiotic, and omega-3 fatty acids. Everything else is secondary.

Which probiotic is best for eczema?

Lactobacillus rhamnosus GG has the deepest evidence base. The Kalliomaki 2001 trial in the Lancet remains the most cited probiotic-eczema study. Multi-strain combinations also show benefit (Lee et al., 2008: 30.7% SCORAD reduction versus 18.8% placebo). Generic "probiotic blends" without specified strains are not interchangeable. Look for products listing specific strains (LGG, L. salivarius LS01, or multi-strain formulations matching published trial compositions). Culturelle is the widely available brand containing LGG. Minimum effective dose: 10 billion CFU per day.

Does vitamin D help eczema?

Yes, with strong evidence. Kim et al. (2016) pooled nine RCTs and found significant SCORAD improvement. The mechanism involves VDR-mediated production of cathelicidin (LL-37), an antimicrobial peptide that protects against S. aureus colonization, a major eczema trigger. Vitamin D also promotes regulatory T cells and suppresses Th2 overactivity. Akan et al. (2020) confirmed that AD patients carry significantly lower 25(OH)D than controls. Target serum levels of 50 to 80 ng/mL with 2,000 to 4,000 IU/day supplementation plus K2.

Is evening primrose oil effective for eczema?

The honest answer: probably not. The Cochrane review (Bamford et al., 2013) evaluated all available RCTs and found no consistent benefit for evening primrose oil or borage oil in atopic dermatitis. The biochemical rationale (bypassing impaired delta-6-desaturase) is sound, but the clinical results have not supported it in well-designed trials. Earlier positive studies had methodological limitations. We grade EPO as Grade C for eczema. If you choose to try it, 500 mg GLA daily (4 to 6 g EPO capsules) for 12 weeks, with measured expectations.

Can I take supplements with Dupixent?

Standard eczema supplements are compatible with dupilumab. Vitamin D, omega-3, zinc, probiotics, and quercetin have no documented interactions with IL-4/IL-13 receptor blockade. Dupilumab targets one arm of Th2 inflammation; these supplements modulate complementary pathways. Inform your dermatologist about all supplements when initiating or continuing biologic therapy. Avoid immune-stimulating supplements (ashwagandha, echinacea, elderberry) regardless of medication status, as they may counteract the therapeutic immune modulation dupilumab provides.

How long do supplements take to improve eczema?

Timelines vary by intervention. Vitamin D requires 4 to 8 weeks to reach therapeutic serum levels. Probiotics need 8 to 12 weeks for measurable SCORAD changes. Fish oil follows a similar 8 to 12 week trajectory. Zinc, if you are deficient, may show improvement in 4 to 6 weeks. Quercetin can modulate itch within 2 to 4 weeks due to its direct mast cell stabilization. One common mistake: abandoning supplements after two or three weeks. Immune modulation is slow biology. Commit to a 12-week trial before assessing whether a supplement protocol is working.

Building Your Eczema Supplement Protocol

Start with the Grade A foundation. Test serum 25(OH)D and correct deficiency with 2,000 to 4,000 IU/day D3 plus K2. This single intervention addresses skin barrier antimicrobial defense, immune regulation, and a deficiency documented in the majority of AD patients.

Add a strain-specific probiotic. LGG at 10 billion CFU or higher is the most evidence-backed choice. Pair it with omega-3 fatty acids (2 to 4 g EPA + DHA daily) if your baseline fish intake is low.

Test zinc. If serum levels are low, add 15 to 30 mg zinc picolinate. The combination of vitamin D, LGG, and zinc showed synergistic benefit in infant AD trials.

Consider quercetin if itch is your dominant symptom. The mast cell stabilization mechanism is well characterized even though the eczema-specific clinical data is thin.

Skip evening primrose oil unless nothing else is working and you want to test it empirically. The Cochrane data says it should not be a first-line choice.

Avoid immune stimulators entirely. Check your multivitamin, greens powder, and "immune support" blends for hidden ashwagandha, echinacea, elderberry, or spirulina. These are counterproductive in Th2-dominant conditions.

Atopic dermatitis is classified as immune-mediated rather than classic autoimmune. The distinction matters clinically: AD involves Th2 skewing rather than the Th1/Th17 autoantibody-driven destruction seen in conditions like Hashimoto's or rheumatoid arthritis. Supplement strategies that work for Th1-dominant autoimmunity do not automatically apply here. Condition-specific evidence matters.

Your optimal protocol depends on severity (mild, moderate, severe), current medications (topical only versus biologics versus systemic immunosuppressants), age, and which deficiencies testing reveals. A supplement approach for mild AD managed with moisturizers and occasional topical steroids differs from one for severe AD on dupilumab.

Take the free 3-minute AutoimmuneFinder quiz to build a personalized supplement protocol matched to your specific condition, severity, and current medications.

This article is for educational purposes only and does not constitute medical advice. Atopic dermatitis is an immune-mediated condition that may require ongoing dermatological supervision. Do not start, stop, or change any supplement or medication without consulting your dermatologist or primary care physician. All dosage recommendations should be discussed with your healthcare provider before implementation. Supplements are not a replacement for prescribed medications including topical corticosteroids, biologics, or other therapies your dermatologist has recommended.